In late December 2023, we reported on how an election-occasioned changing of the guard around the Kentucky Opioid Abatement Advisory Commission (KYOAAC) left an ambitious plan to cleave off $42m in opioid settlement funds for ibogaine research politically untenable (See Kentucky’s $42m Ibogaine Funding Appears Dead in the Water).Once that became clear, the loose coalition of ibogaine funding…


Previous articlePα+ Psychedelic Patent Analysis: A Mebufotenin Melee (Dec ’23 & Jan ’24)
Next articlePT489 – Psychedelics, Art Therapy, and the Creative Process